BioXcel Therapeutics Inc
NASDAQ:BTAI

Watchlist Manager
BioXcel Therapeutics Inc Logo
BioXcel Therapeutics Inc
NASDAQ:BTAI
Watchlist
Price: 2.01 USD -2.9% Market Closed
Market Cap: 44m USD

Wall Street
Price Targets

BTAI Price Targets Summary
BioXcel Therapeutics Inc

There are no price targets for BTAI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BioXcel Therapeutics Inc Competitors:
Price Targets
DAWN
Day One Biopharmaceuticals Inc
171% Upside
CVAC
CureVac NV
5% Downside
BNTX
BioNTech SE
47% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
10% Upside
002252
Shanghai RAAS Blood Products Co Ltd
11% Upside
CAPR
Capricor Therapeutics Inc
50% Upside
2162
KeyMed Biosciences Inc
56% Upside
NVAX
Novavax Inc
97% Upside

Revenue
Forecast

Revenue Estimate
BioXcel Therapeutics Inc

The compound annual growth rate of BioXcel Therapeutics Inc's revenue for the next 3 years is 145%.

N/A
Past Growth
145%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BioXcel Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
BioXcel Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-93%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BTAI's stock price target?
Not Available

BTAI doesn't have any price targets made by Wall Street professionals.

What is BioXcel Therapeutics Inc's Revenue forecast?
Projected CAGR
145%

The compound annual growth rate of BioXcel Therapeutics Inc's revenue for the next 3 years is 145%.

Back to Top